PharmaXportsTrusted Medicines. Healthier Tomorrow.
Tier 1 — Highly regulated

Pharma Export to Europe & UK from India

A highly regulated, quality-gated market requiring EU-GMP inspection and, for APIs, an EDQM Certificate of Suitability (CEP). This is not a realistic finished-formulation market for a new merchant exporter in year one — WHO-GMP certification alone is not sufficient. The realistic route into this corridor is bulk API supply backed by a CEP or DMF, or acting as the distribution arm of an already EU-GMP-approved manufacturer.

Countries: European Union member states, United Kingdom, Switzerland

What Sells in This Market

APIs with EDQM CEPGenerics (via an approved manufacturing partner)Biosimilars

Regulatory Pathway

Pathway

MAA / decentralised procedure (EU), MHRA (UK). APIs require an EDQM Certificate of Suitability (CEP) or equivalent DMF.

Plant Requirement

EU-GMP inspected facility. WHO-GMP alone is not sufficient for finished formulations.

Timeline

2–4 years per product from dossier start

Barrier to Entry

Very high

Regulatory Considerations

  • Not a realistic finished-formulation entry market for a new exporter — the honest route is API supply or partnering with an already-approved manufacturer
  • APIs require an EDQM CEP or equivalent DMF, confirmed per manufacturing partner
  • The EU's own biocidal-products and novel-food regimes can be stricter than the drug route for adjacent categories

Documentation

  • Commercial invoice
  • Packing list
  • Certificate of Origin (preferential where an FTA applies)
  • Certificate of Analysis
  • EDQM CEP or DMF reference (API)
  • EU-GMP certificate of the manufacturing plant

Market Opportunity

High-value but a multi-year market. We support buyers here primarily through API supply with CEP/DMF documentation, and through distribution partnerships with EU-GMP-approved Indian manufacturers rather than claiming direct finished-dose registration capability we do not yet hold.

Frequently Asked Questions

Not as a new merchant exporter in year one — this requires an EU-GMP inspected manufacturing partner and a multi-year dossier process. We can support API supply backed by a CEP/DMF, and can discuss partnership routes for finished-dose products with buyers who have specific requirements.

Typical Buyer Types

  • Licensed importers and distributors (finished dose, via approved partners)
  • Formulators and manufacturers (API)
Requirements vary by product and destination. This page describes the general market landscape, not company-specific sales coverage or a guarantee of registration outcome.
Request a Quote for Europe & UK

Related Products for This Market

Ready to Source for Europe & UK?

Get an Export QuoteView Compliance Framework
Get a Quote